Discussion Session: Debating Whether Patient Organization Leaders Should be Involved in Regulatory Meetings to Optimize Patient Transparency
Time: 1:15 pm
day: Day One PM
Details:
- Comparing different views of early patient groups implementation during regulatory meetings to utilize patient voices
- Assessing the risks and benefits of early patient implementation to evaluate its necessity
- Reviewing the process of how patient insights are passed to regulatory bodies to ensure clear translation of patients’ needs
